(Received for publication May 30, 1983) Conversion of the monovalent polyether antibiotic monensin into a series of urethane derivatives substituted at C-26 causes a ten-fold increase in the cation transporting properties of the antibiotic as well as making the resulting semisynthetic urethanes divalent ionophores.
These changes must in part account for the enhanced antimicrobial activities of the urethanes. The most active derivatives are the phenylurethanes which are ten times more active in vitro against Gram-positive bacteria and unlike monensin are active against Candida albicans and Penicillium digitatum.
Another novel activity exhibited by four of the urethanes was against Plasmodium berghei, the causative agent for malaria.
The isolation of the novel antibiotics X-14667A and X-14667B from Streptomyces cinnamonensis subsp. urethanefaciens was recently described'). The confirmation of their structures as 2-phenethylurethanes of monensins B=) and As) respectively by synthesis using 2-phenethylisocyanate suggested the synthesis of other monensin urethanes (1 -14) . In a similar study with the polyether antibiotic laidlomycin'•5>, monoacylation has led to derivatives that display enhanced activity towards favorably altering rumen fermentation and preventing avian coccidiosis8. In the study described here, many of the semisynthetic monensin urethanes displayed greater activity than monensin (15) in a variety of in vitro and in vivo screens. The derivatives were active in vitro against Gram-positive bacteria, Penicillium digitatum, Candida albicans, the anaerobes Bacteroides fragilis and Clostridium histolyticum and C. septicum and Treponema hyodvsenteriae. In addition several of the urethanes were active against Eimeria tenella in chicks and Plasmodium berghei in mice.
Chemistry
The preparation of antibiotics X-14667A (2) and X-14667B (3) from monensin B and A (15) has been described previously'). Table 1 .
Transport Properties
The U-tube system described by ASHTON and STEINRAUF7 was employed to measure the monovalent and divalent cation transport properties of several monensin urethanes. A glass U-tube was filled with The experiment was started by the addition of the respective labelled metal chloride and the chloroform phase separating the two aqueous phases was then gently stirred with a magnetic stirrer overnight. The percentage of labelled cation transported overnight was determined by counting 50 Id samples taken from both aqueous phases with 10 ml Aquasol (New England Nuclear, Boston, Mass.) in an Intertechnique liquid scintillation spectrometer. The results are summarized in Table 2 .
From the results in Table 2 , there is a clear indication that the urethane moiety attached to the hydroxyl group at C-26 of monensin causes a ten-fold enhancement in the monovalent cation-transporting properties of the parent antibiotic. In addition, the urethanes have the ability to transport divalent cations which monensin does not. These divalent properties are particularly marked in the monensin phenylurethanes (7-14).
A possible explanation for the enhanced cation transporting properties of these semisynthetic deriva- Table 4 . In vitro MIC's (jig/ml) of monensin urethanes against a mold, a yeast and a spirochete. 
Biological Properties
The in vitro activity of the fourteen semisynthetic monensin urethanes against ten Gram-positive bacteria are compared with that of monensin in Table 3 . In the case of monensin (15) only one bacteria, Bacillus sp. E was sensitive at MIC levels less than 1 jig/ml. Apart from the monensin urethanes 1 and 2, all the semisynthetic derivatives were active against three or more bacteria at levels less than 1 jig/ml with increasing activity down the Table to the phenyl derivatives, 8-14 which were active against between seven and nine of the ten Gram-positive microorganisms tested at levels less than 1 i g/ml.
Against the most sensitive organism, Bacillus sp. E, five of the nionensin phenylurethanes (9 --13) were active at levels less than 0.1 jig/ml.
The monensin urethanes are also active in vitro against P. digitatum, C. albicans and T. hvodysenteriae (Table 4) . Whereas monensin was inactive against both the mold, P. digitatum and the yeast, C.
albicans, the cyclohexyl-(6) and phenylurethanes (7-14) were all active against both with monensin chlorophenylurethane (13) exhibiting activity against C. albicans at less than 0.1 i g/ml.
In addition, four of the phenylurethanes (7, 9, 11 and 14) were compared with monensin (15) in vitro against three anaerobes, Bacteroides fragilis, C. histolyticum and C. septicum. The activities of the phenylurethanes were very similar to monensin against B. fragilis with MIC values between 25-100 tug/ml but were ten times more active against the two Clostridia with MIC values of 0.080.31 iug/ml compared to 3.1 pg/ ml for monensin. In Table 5 , the in vivo activities of the monensin urethanes are summarized. The 24 hour LD50 values and the antimalarial activities vs. P. berghei were determined in the mouse and the coccidiostat activities vs. E. tenella were studied in chicks.
The toxicities (i.p. and p.o.) of the alkylurethanes of monensin (1-5) were all less than the parent antibiotic (15), but the phenylurethanes were very similar. One exception was the bromophenylurethane (12) which was approximately three times less toxic than monensin and in addition was active against P. berghei in mice at 16 mg/kg p.o. whereas monensin was inactive at five times that level. Phenylurethane (8) and chlorophenylurethane (13) derivatives were also active against P. berghei in mice, and at even lower levels than 12, namely 4 and 2 mg/kg p.o. respectively.
In regard to the coccidiostat activity vs. E. tenella in chicks, the most active derivatives were the fluoro-, bromo-, chloro-and nitrophenylurethanes (10, 12, 13 and 14) followed by the (R)-1-phenethyl, cyclohexyl-, phenyl-, methylphenyl-and iodophenylurethanes (4, 6, 8, 9 and 11) which were about on a par with the parent antibiotic, monensin (15).
Conclusions
The conversion of monensin to its C-26 hydroxyl urethane derivatives has a profound effect on the cation transporting properties of the antibiotic. The ability of monensin to transport Rb+ is increased ten-fold and in addition these semi-synthetic urethanes can cause the transport of Ca`+ which monensin cannot.
This change in physical chemical properties accounts in part for the enhanced biological activity of some of the urethanes described in tats report. ine most active aerivatives are the pnenyiuretnanes which are approximately one order of magnitude more active in vitro against Gram-positive bacteria than monensin.
In addition, the phenylurethanes, unlike monensin, are active against P. digitatum and C. albicans.
When tested in mice, three of the phenylurethanes are active against P. berghei at levels ranging from 2-16 mg/kg whereas monensin is inactive at 80 mg/kg.
Finally, the phenylurethanes exhibit enhanced coccidiostat activity against E. tenella in chicks. V.
